KarthikSureshMD

Critical Care Medicine, Pleural Disease

Associate Professor of Medicine

Dr. Suresh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10751 Falls Road
Falls Concourse Suite 412
Lutherville, MD 21093
Phone+1 410-550-5864

Fax+1 410-367-2376

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2016
Johns Hopkins UniversityChief Residency, Internal Medicine, 2012 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
University of Louisville School of MedicineClass of 2008
University of LouisvilleBS, Mathematics , 2000 - 2004

PubMed

Distinct single cell transcriptional profile in CD4+ T-lymphocytes among obese children with asthma.
Vickram Tejwani, Rulin Wang, Andres Villabona-Rueda, Karthik Suresh, Tianshi David Wu
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2025-01-27
Targeting Endothelial Cell Mitochondrial Quality Control in PAH.
Mahin Gadkari, Karthik Suresh
Circulation Research. 2025-01-17
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.
Hongyang Pi, Lu Xia, Olivier Boucherat, Karthik Suresh, Anna R Hemnes
Circulation. Heart Failure. 2024-11-01

Journal Articles

Immune-Related (IR)-Pneumonitis During the COVID-19 Pandemic: Multidisciplinary Recommendations for Diagnosis and Management
Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Clare Rock, Julie R Brahmer, Journal For Immunotherapy of Cancer
Impact of Checkpoint Inhibitor Pneumonitis on Survival in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy
Karthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
Karthik Suresh, David Feller-Kopman, Lonny Yarmus, Sonye K Danoff, Journal of Thoracic Oncology

Researchers Characterize Lung Inflammation Associated with Some Cancer ImmnunotherapySeptember 5th, 2019
Pharmacovigilance Needed for Immune Checkpoint Inhibitor Therapy in NSCLCAugust 29th, 2019